Share this post on:

Name :
MEF2B Polyclonal Antibody

Documents :
DataSheet Material Safety Data Sheets (MSDS)

Description :
Polyclonal antibody to MEF2B

Tested applications :
WB

Species reactivity :
Mouse

Alternative names :
MEF2B antibody; RSRFR2 antibody; myocyte enhancer factor 2B antibody

Immunogen :

Isotype :
Rabbit IgG

Preparation :
Antigen: A synthetic peptide corresponding to a sequence within amino acids 1-100 of human MEF2B (NP_005910.1).

Clonality :
Polyclonal

Formulation :
PBS with 0.02% sodium azide, 50% glycerol, pH7.3.

Storage instructions :
Store at -20℃. Avoid freeze / thaw cycles.

Applications :
WB 1:500 – 1:2000

Background :
Transcriptional activator which binds specifically to the MEF2 element, 5′-YTA[AT](4)TAR-3′, found in numerous muscle-specific genes. Activates transcription via this element. May be involved in muscle-specific and/or growth factor-related transcription.

References :

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Camrelizumab MedChemExpress
Magrolimab Description
Acetyl CoA synthetaseAntibody: Acetyl CoA synthetaseAntibody is a non-conjugated and Rabbit origined monoclonal antibody about 79 kDa, targeting to Acetyl CoA synthetase. It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.

Share this post on:

Author: Gardos- Channel